OGEN ORAGENICS INC
NYSE · SEC CIK 1174940 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $394.80 2 sales by 1 insiders
- Filings on record
- 62 since 2021-12-17, latest 2026-07-07 17:51
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Telling Fred | Dir | — | $394.80 |
Transactions 28
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DA | 2026-01-22 | 2025-12-12 | OGEN | Telling Fred | Dir | S - Sale | $0.94 | -210 | 948 | -18% | -$197.40 |
| D | 2025-12-15 | 2025-12-12 | OGEN | Telling Fred | Dir | S - Sale | $0.94 | -210 | 34.5K | -0.6% | -$197.40 |
| M | 2025-06-18 | 2025-06-17+ | OGEN | Odyssey Health, Inc. | 10% | S - Sale | $4.32 | -7,044 | 0 | -100% | -$30.4K |
| M | 2025-06-16 | 2025-06-13+ | OGEN | Odyssey Health, Inc. | 10% | S - Sale | $4.36 | -10.0K | 7,044 | -59% | -$43.6K |
| DI | 2024-12-13 | 2024-12-11 | OGEN | KOSKI ROBERT C | Dir | C - Cnv Deriv | — | +5,000 | 23.4K | +27% | — |
| 2024-12-09 | 2024-12-06 | OGEN | DUNTON ALAN W | Dir | S - Sale | $0.36 | -66 | 25.6K | -0.3% | -$23.76 | |
| 2024-12-09 | 2024-12-06 | OGEN | Telling Fred | Dir | S - Sale | $0.36 | -3,597 | 34.7K | -9% | -$1,295 | |
| 2023-12-01 | 2023-11-30 | OGEN | Telling Fred | Dir | S - Sale | $3.57 | -3,500 | 38.3K | -8% | -$12.5K | |
| 2023-08-10 | 2023-08-08 | OGEN | Murphy Kimberly M | CEO, Pres, Dir | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 | |
| 2023-08-10 | 2023-08-08 | OGEN | Telling Fred | Dir | A - Grant | $0.00 | +25.0K | 41.8K | +148% | $0 | |
| 2023-08-10 | 2023-08-08 | OGEN | KOSKI ROBERT C | Dir | A - Grant | $0.00 | +25.0K | 25.7K | +3,628% | $0 | |
| 2023-08-10 | 2023-08-08 | OGEN | DUNTON ALAN W | Dir | A - Grant | $0.00 | +25.0K | 25.7K | +3,628% | $0 | |
| 2023-08-10 | 2023-08-08 | OGEN | POPE CHARLES L | Dir | A - Grant | $0.00 | +25.0K | 25.5K | +5,308% | $0 | |
| 2023-08-10 | 2023-08-08 | OGEN | Huffman Janet | CFO, Sec, Treas | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 | |
| 2023-01-03 | 2022-12-29 | OGEN | KOSKI ROBERT C | Dir | S - Sale | $0.11 | -36.6K | 176.2K | -17% | -$4,031 | |
| I | 2023-01-03 | 2022-12-30 | OGEN | KOSKI ROBERT C | Dir | S - Sale | $0.11 | -42.4K | 1.10M | -4% | -$4,659 |
| MI | 2022-12-16 | 2022-12-14+ | OGEN | KOSKI ROBERT C | Dir | S - Sale | $0.18 | -165.5K | 1.14M | -13% | -$29.8K |
| I | 2022-12-15 | 2022-12-14 | OGEN | KOSKI ROBERT C | Dir | S - Sale | $0.18 | -4,503 | 1.31M | -0.3% | -$810.54 |
| I | 2022-12-12 | 2022-12-09 | OGEN | KOSKI ROBERT C | Dir | S - Sale | $0.2 | -48.8K | 1.31M | -4% | -$9,759 |
| I | 2022-12-09 | 2022-12-08 | OGEN | KOSKI ROBERT C | Dir | S - Sale | $0.2 | -13.0K | 1.36M | -0.9% | -$2,607 |
| MI | 2022-12-01 | 2022-11-29+ | OGEN | KOSKI ROBERT C | Dir | S - Sale | $0.19 | -400.0K | 1.58M | -20% | -$76.0K |
| 2022-06-21 | 2022-06-17 | OGEN | Telling Fred | Dir | P - Purchase | $0.29 | +10.1K | 1.01M | +1% | +$2,924 | |
| M | 2022-05-25 | 2022-05-23+ | OGEN | Telling Fred | Dir | P - Purchase | $0.29 | +82.2K | 921.2K | +10% | +$23.8K |
| 2022-05-23 | 2022-05-20 | OGEN | Telling Fred | Dir | P - Purchase | $0.28 | +65.7K | 917.7K | +8% | +$18.4K | |
| M | 2022-05-20 | 2022-05-18+ | OGEN | Telling Fred | Dir | P - Purchase | $0.2758 | +72.1K | 852.0K | +9% | +$19.9K |
| M | 2022-04-01 | 2022-03-30+ | OGEN | Telling Fred | Dir | P - Purchase | $0.3568 | +183.8K | 779.9K | +31% | +$65.6K |
| 2022-03-30 | 2022-03-29 | OGEN | Sullivan Michael O'Keefe | CFO, Interim PEO | P - Purchase | $0.35 | +20.0K | 34.3K | +140% | +$7,000 | |
| MI | 2022-01-03 | 2021-12-30+ | OGEN | KOSKI ROBERT C | Dir | P - Purchase | $0.466 | +1.00M | 977.4K | New | +$466.0K |
Purchase Sale Sale after option exercise All abbreviations